Zdrowie i gospodarka · 29/03/2005

FDA Releases Draft Guidance for Developing Drugs for Systemic Lupus Erythematosus Treatment

The FDA has made available a draft guidance document outlining recommendations for the pharmaceutical industry on developing drugs to treat systemic lupus erythematosus (SLE), a chronic autoimmune disease. The guidance covers key aspects of drug development, including measuring disease activity and assessing treatment efficacy.